Vanguard Fiduciary Trust
CGON icon

Vanguard Fiduciary Trust’s CG Oncology CGON Stock Holding History

Vanguard Fiduciary Trust’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.2M Buy
538,289
+68,032
+14% +$4.45M 0.01% 1007
2026
Q1 		$31.8M Buy
+470,257
New +$26.6M 0.01% 1036

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Fiduciary Trust's CGON Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its CG Oncology (CGON) stake by 14% in Q2 2026, buying an estimated $4.45M and bringing the position to 538,289 shares worth $38.2M. The position accounts for 0.01% of the portfolio, ranked #1007.

Vanguard Fiduciary Trust first reported a position in CGON in Q1 2026 and has held it in 2 quarters since. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Vanguard Fiduciary Trust held 538,289 shares of CG Oncology worth $38.2M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 68,032 CG Oncology shares in Q2 2026, an estimated $4.45M.
  • CG Oncology made up 0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #1007 holding.
  • Vanguard Fiduciary Trust first reported a position in CG Oncology in Q1 2026 and has held it in 2 quarters since.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.